by | Jan 13, 2023 | Clinical case
Watch the clinical case discussion by Prof. Dr. Paolo Gontero to learn more about the advantages of alternating cystoscopy with a urinary marker for the surveillance of intermediate-risk non-muscle-invasive bladder cancer (NMIBC). Prof. Dr. Paolo Gontero is Professor...
by | Dec 15, 2022 | Clinical case
True or false? The sensitivity and negative predictive value for detecting high-grade UTUC* is higher with Bladder EpiCheck compared to cytology. Submit your answer and read the opinion of Mr. Hugh Mostafid A) True B) False * Upper tract urothelial...
by | Nov 25, 2021 | Clinical case
Jimmy is a 68-year-old retired kindergarten teacher. Whenever he can, he volunteers to read to children during story time at the local library. He was first diagnosed with low-grade non-muscle-invasive bladder cancer (NMIBC) 12 years ago. Since then, he has had two...
by | Nov 15, 2021 | Clinical case
Cystoscopy* has a high sensitivity for detecting carcinoma in situ (CIS) in non-muscle-invasive bladder cancer (NMIBC). Therefore, it can accurately rule out this high-grade and aggressive tumour. Submit your answer and read the opinion of Dr. Joost Boormans...
by | Jun 1, 2021 | Clinical case
David is a 71-year-old amateur golfer. Despite the closing of the golf club due to the COVID-19 pandemic, he enjoys playing a game in his 8 square meter garden using a miniature golf set. He was diagnosed with non-muscle-invasive bladder cancer (NMIBC) 3.5 years ago....
by | May 11, 2021 | Clinical case
Which biomarker metric is dependent on disease prevalence, and therefore cannot be compared between different cohorts? Submit your answer and read the opinion of Mr. Hugh Mostafid. A) Sensitivity B) NPV* * negative predictive value C) Specificity...
